As a well-known oncogene, TCGA data showed that high expression of c-Myc was also found to be associated with poor prognosis of glioma patients with an AUC of 0.992 (Fig. S5A, B), which was also positively correlated with CCND1 expression (Fig. S5C). Here, CCND1 is linked to central nervous system cancer.